KLAS Contact
2021 BEST IN KLAS
Preferences
Related Series
2014
2011
2010
2006
Related Segments
Related Products
Related Vendors
Related Articles
Home Health EHR 2021
A Look at the Experience of Midsize to Large Home Health Agencies
Author
Paul Hess
Author
Jonathan Christensen
Current Time Inside Cache Tag Helper: 1/26/2022 12:34:26 PM and Model.reportId = 1758
Home health agency growth and consolidation have resulted in increasingly larger agencies, many of whom are seeking economies of scale and need strong IT solutions to drive them into the future. This report highlights home health EHR vendors’ performance among midsize and larger home health agencies (average daily census of >200) and explores a few key questions:
- Which vendors are most often used by midsize or larger organizations, and how do they perform?
- Are other vendors challenging Homecare Homebase’s significant presence in the largest agencies?
- How have recent acquisitions impacted satisfaction for MatrixCare (Brightree), Netsmart, and WellSky customers?
- Which solutions are most commonly used by independent agencies versus those owned by health systems?
Key Findings:
- MatrixCare Home Health Top Performer for Midsize Independent Agencies; Epic Provides Strong Experience for Health System–Owned Agencies
- Homecare Homebase Breadth of Functionality Drives Loyalty; Support Has Declined
- WellSky Product Meets Needs; Customers Report Dip in Support amid Vendor Growth
- Netsmart Customers Looking Elsewhere as Product Development Lags and Vendor Focus Shifts to myUnity Platform
Writer
Amanda Wind Smith
Designer
Jess Gibb
Project Manager
Natalie Jamison
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.